skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

4757

Biologics: Targets & Therapy

(604,965) Views

Editor in Chief Dr Doris Mangiaracina Benbrook

1177-5475

Current and future applications of the anti-IgE antibody omalizumab
Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini

Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki Okuda

Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley, Andrew H Ko

Sunitinib for advanced renal cell cancer
Chris Coppin

Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie, Chien-Fu Hung, Richard Roden, T-C Wu

Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E Kalb

The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
David A Schwartz

Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia Castellini

Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz

Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich, Boris Nohé

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick, Terry Diamond

A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Robert C Fang, Robert D Galiano

Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano, Sagar Lonial

Abciximab: a reappraisal of its use in coronary care
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, et al

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi, Enrica Morra

Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mary F Mulcahy

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Bella Kaufman, Steven Stein, Michelle A Casey, Beth O Newstat

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed